The Early Integrated Intervention for Child Brain-developmental Disorders in China

NCT03847402 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2022-01-11

No results posted yet for this study

Summary

This study is focused on developing the early integrated intervention for child brain-developmental disorders, including globe developmental delay (GDD), autism spectrum disorder (ASD), and attention deficit-hyperactivity disorder (ADHD), in China.

Conditions

  • Brain Developmental Diseases
  • Autism Spectrum Disorder
  • Global Developmental Delay
  • Attention Deficit-Hyperactivity Disorder

Interventions

BEHAVIORAL

The early integrated intervention for GDD

The early integrated intervention for GDD integrates developmental approaches with strategies of applied behavior analysis.

BEHAVIORAL

The early integrated intervention for ASD

The theoretical underpinnings of the early integrated intervention for ASD originate from Early Start Denver Model.

BEHAVIORAL

The early integrated intervention for ADHD

The methods of the early integrated intervention for ADHD includes behavior training, sensory integration training and psychological counseling

BEHAVIORAL

community intervention for ASD

TEACCH (Treatment and Education of Autistic and related Communication- handicapped Children) intervention or ABA(applied behavior analysis) intervention

BEHAVIORAL

Community intervention for GDD

community intervention based on developmental approaches

BEHAVIORAL

community intervention for ADHD

School and family education

Sponsors & Collaborators

  • National Key Research and Development Program of China

    collaborator UNKNOWN
  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Xiu Xu, MD, PhD · Children's Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2021-06-30
Completion
2021-07-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847402 on ClinicalTrials.gov